Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

Medical College of Wisconsin

Status: Active, not recruiting

Conditions: Breast Cancer Stage IV; Breast Cancer; Breast Cancer Invasive; Breast Adenocarcinoma; Breast Cancer in Situ; Breast Cancer Stage; Breast Neoplasms

Study type: Observational

Funder types: Other

Identifiers

NCT06234488

PRO00043417

Details and patient eligibility

About

There is no granular retrospective data on breast cancer in transgender and gender-diverse (TGD) persons from a contemporary and diverse American cohort. The purpose of this investigation is to aggregate data from multiple institutions to describe the risk, diagnosis, management, and outcomes of TGD persons with breast cancer in effort to identify opportunities for future intervention studies to eliminate breast cancer disparities for this population.

Enrollment: 125 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age 18 years of age or older
2. Breast cancer diagnosis (including DCIS)
3. Persons who identify as gender and/or sex that is different from the sex they were assigned at birth

Exclusion criteria

1. Age <18 at time of breast cancer diagnosis
2. Cis-gendered persons

Trial design

125 participants in 1 patient group

Transgender and Gender-Diverse Persons with Breast Cancer

Description:

Patients who had a breast cancer diagnosis (including those with ductal carcinoma in situ (DCIS)), who were age ≥18 years at the time of diagnosis and identify as a gender and/or sex that is different from their sex assigned at birth (e.g., transgender, nonbinary, genderqueer, etc.) between 1/1/1990 - 7/1/2023.